Kidney disease and kidney cancer are not the same condition. They affect the kidneys in fundamentally different ways: kidney disease is a gradual loss of kidney function, while kidney cancer is the uncontrolled growth of abnormal cells in kidney tissue. The two conditions have different causes, different symptoms, different diagnostic tests, and very different treatments. That said, they share some surprising connections that are worth understanding.
What Each Condition Actually Is
Chronic kidney disease (CKD) is a slow, progressive decline in your kidneys’ ability to filter waste from your blood. It affects virtually all cell types across the kidney’s filtering units and, over time, leads to scarring that causes irreparable damage to the tiny blood vessels and structures that do the filtering work. CKD is classified into five stages based on how well your kidneys are still functioning, measured by a number called your estimated glomerular filtration rate (eGFR). Stage 1 means your kidneys still filter at 90 or above (near normal, but with signs of damage like protein in the urine), while Stage 5 means filtration has dropped below 15 and you likely need dialysis.
Kidney cancer, by contrast, is a tumor. About 85% of kidney cancers are a type called renal cell carcinoma, which starts in the lining of the kidney’s tiny filtering tubes. Instead of the kidney slowly losing its ability to work, a group of cells begins multiplying out of control and forms a mass. That mass can stay confined to the kidney or, over time, spread to lymph nodes, blood vessels, or distant organs. Kidney cancer is staged not by how well the kidney works, but by the size of the tumor and whether it has spread. A Stage I tumor is 7 centimeters or smaller and still contained within the kidney. Stage IV means the cancer has reached other parts of the body.
How Symptoms Compare
Both conditions can be sneaky in their early stages. CKD often produces no obvious symptoms until significant function is lost. Early signs tend to be vague: fatigue, swelling in the ankles or feet, changes in how often you urinate, and foamy or dark urine.
Kidney cancer also tends to be silent at first. When symptoms do appear, they can include blood in the urine (which may look pink, red, or cola-colored), persistent pain in the back or side, unexplained weight loss, loss of appetite, ongoing tiredness, fever, and night sweats. The overlap in symptoms like fatigue and changes in urine is one reason people sometimes confuse the two conditions. But blood in the urine, a palpable lump in the side, and unexplained weight loss point more specifically toward cancer, while progressive swelling, high blood pressure, and worsening lab values over time are hallmarks of CKD.
Different Causes and Risk Factors
The most common drivers of chronic kidney disease are diabetes and high blood pressure, which together account for the majority of cases. These conditions damage the delicate blood vessels inside the kidney over years or decades, gradually reducing its filtering capacity. Other causes include autoimmune conditions, inherited disorders, repeated kidney infections, and long-term use of certain pain medications.
Kidney cancer has a different risk profile. Smoking is one of the strongest risk factors. Obesity, exposure to certain workplace chemicals, and inherited genetic syndromes also raise the risk. Interestingly, high blood pressure appears on both lists, serving as a shared risk factor for both conditions.
Certain toxins, such as some painkillers and a plant-derived compound called aristolochic acid, can cause both chronic kidney inflammation and urinary tract cancers, illustrating how the two diseases sometimes share root causes even though they develop in completely different ways.
How Each Is Diagnosed
Doctors use very different tools to identify these conditions. CKD is primarily diagnosed through blood and urine tests. A blood test measures creatinine (a waste product your kidneys should be clearing) and uses it to estimate your eGFR. A urine test checks for albumin, a protein that leaks into urine when the kidney’s filters are damaged. These simple, inexpensive tests can catch CKD long before symptoms appear, which is why they’re part of routine checkups for people with diabetes or high blood pressure.
Kidney cancer, on the other hand, is typically found through imaging. An ultrasound, CT scan, or MRI can reveal a mass or tumor in the kidney. Many kidney cancers are actually discovered by accident during imaging ordered for an unrelated reason. If a suspicious mass is found, a biopsy (removing a small tissue sample for examination under a microscope) may be performed to confirm whether it’s cancerous and what type of cancer it is.
Treatment Looks Completely Different
The treatment paths for these two conditions have almost nothing in common. CKD management focuses on slowing the loss of kidney function. In earlier stages, that means controlling blood pressure, managing blood sugar if you have diabetes, adjusting your diet, and taking medications that protect the kidneys. If the disease progresses to Stage 5, the options narrow to dialysis (a machine or fluid exchange that does the filtering work your kidneys can no longer handle) or a kidney transplant.
Kidney cancer treatment centers on removing or destroying the tumor. For cancers caught early and still confined to the kidney, surgery to remove part or all of the affected kidney is the standard approach. For more advanced cases where the cancer has spread, treatment may involve drugs that target the tumor’s blood supply, immunotherapy that trains the immune system to attack cancer cells, or radiation. The goal shifts from preserving kidney function to eliminating malignant tissue.
The Survival and Outlook Picture
The prognosis for each condition depends heavily on when it’s caught. Kidney cancer that’s still localized to the kidney has a five-year relative survival rate of 93%, based on people diagnosed between 2015 and 2021. If it has spread to nearby lymph nodes or tissues, that drops to 76%. Once it has reached distant organs, the five-year survival rate falls to 19%. Across all stages combined, the rate is 79%. An estimated 81,610 new cases of kidney cancer were expected in the United States in 2024, with about 14,390 deaths.
CKD affects far more people but progresses on a very different timeline. It’s a lifelong condition that can be managed for years or even decades when caught early. Many people with Stage 1 or 2 CKD never progress to kidney failure. For those who do reach Stage 5, life expectancy depends on access to dialysis or transplant and overall health. The disease itself is rarely listed as a cause of death; instead, the cardiovascular complications that accompany advanced CKD are the primary threat.
How the Two Conditions Are Connected
Despite being fundamentally different diseases, kidney disease and kidney cancer have a closer biological relationship than you might expect. At the cellular level, both conditions involve the kidney’s response to low oxygen levels. In cancer, that oxygen-sensing system malfunctions and drives tumor growth. In CKD, restricted blood flow starves kidney cells of oxygen and triggers scarring.
More practically, having CKD appears to increase your risk of developing cancer. Research published in the Journal of Nephrology found that for every 10-point drop in eGFR, cancer risk increased by 29%, independent of age and smoking. The greatest risk was seen when eGFR fell below 40. People who receive kidney transplants also face higher cancer risk, primarily because the immunosuppressive drugs needed to prevent organ rejection weaken the body’s ability to detect and destroy abnormal cells.
The relationship runs in the other direction too. Cancer treatments, including certain chemotherapy drugs, can damage the kidneys and trigger or worsen CKD. And tumors themselves can sometimes impair kidney function directly by obstructing urine flow or invading kidney tissue. So while kidney disease and kidney cancer are distinct conditions, they can influence and even cause each other in ways that make monitoring both important for people living with either diagnosis.